<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03145870</url>
  </required_header>
  <id_info>
    <org_study_id>PI2014_843_0009</org_study_id>
    <nct_id>NCT03145870</nct_id>
  </id_info>
  <brief_title>Prevalence of Asymptomatic Thrombosis in Multiple Myeloma</brief_title>
  <official_title>Prevalence of Asymptomatic Thrombosis in Multiple Myeloma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Malignant hemopathies, such as solid cancers, increase the risk of venous and arterial&#xD;
      thromboembolic events. The incidence of symptomatic venous thromboembolic events is&#xD;
      particularly high in myeloma, linked to the usual risk factors for venous thromboembolic&#xD;
      disease, biological risk factors specific to myeloma, and especially to its treatments.&#xD;
&#xD;
      The prevalence of asymptomatic venous thromboembolic events and arterial events are not known&#xD;
      to date and remain important data for planning a possible randomized study to determine the&#xD;
      most suitable thromboprophylaxis in these patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    investigator choice&#xD;
  </why_stopped>
  <start_date type="Actual">June 3, 2014</start_date>
  <completion_date type="Actual">May 16, 2017</completion_date>
  <primary_completion_date type="Actual">May 16, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Analysis of the occurrence of venous thromboembolic events via transverse Doppler echo</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Thrombosis</condition>
  <condition>Multiple Myeloma</condition>
  <arm_group>
    <arm_group_label>Patient with multiple symptomatic myeloma</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Echoing of the lower limbs and measuring the systolic pressure index</intervention_name>
    <description>Echoing of the lower limbs and measuring the systolic pressure index</description>
    <arm_group_label>Patient with multiple symptomatic myeloma</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient major age â‰¥18 years&#xD;
&#xD;
          -  Patients with symptomatic myeloma meeting the definition of the International Myeloma&#xD;
             Working Group, regardless of the therapeutic line, including patients in remission and&#xD;
             untreated.&#xD;
&#xD;
          -  Patient having given informed consent, signed.&#xD;
&#xD;
          -  Patient benefiting from a social security scheme&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with non-symptomatic myeloma (stage I) or gammapathy of unknown significance&#xD;
             (MGUS).&#xD;
&#xD;
          -  Patient undergoing antithrombotic treatment for deep or superficial venous thrombosis&#xD;
             and / or pulmonary embolism at the time of inclusion.&#xD;
&#xD;
          -  Patients with occlusive arterial disease of the lower limbs known at the time of&#xD;
             inclusion.&#xD;
&#xD;
          -  Minors, protected adults and patients deprived of liberty or not affiliated to a&#xD;
             social security scheme&#xD;
&#xD;
          -  Pregnant woman&#xD;
&#xD;
          -  Patient unable to express consent.&#xD;
&#xD;
          -  Patient under guardianship or curatorship or patient deprived of public liberty&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Amiens Picardie</name>
      <address>
        <city>Amiens</city>
        <state>Picardie</state>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 4, 2017</study_first_submitted>
  <study_first_submitted_qc>May 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 9, 2017</study_first_posted>
  <last_update_submitted>July 15, 2020</last_update_submitted>
  <last_update_submitted_qc>July 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Myeloma</mesh_term>
    <mesh_term>Neoplasms, Plasma Cell</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

